A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

Clinical trial NCT05440656 · COMPLETED

Trial details

NCT number: NCT05440656
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Severe Eosinophilic Asthma

Start date: 2022-06-29
Primary completion: 2025-04-13
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.